Citi Pharma gets CCP Nod for Pakheim acquisition

MG News | October 19, 2026 at 09:53 AM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

October 19, 2026 (MLN): The Competition Commission of Pakistan (CCP) has authorized the proposed acquisition of 100% shareholding of Pakheim International Pharma (Private) Limited by Citi Pharma Limited (PSX: CPHL), the pharmaceutical company has stated in a filing to the Pakistan Stock Exchange.

The company has received the CCP’s order dated October 9, 2026, passed in Case No. 1614/Merger-CCP/2026. The authorization follows the commission’s review of the proposed transaction and its determination that the deal does not raise competition concerns.

The acquisition will proceed under the terms of the Share Purchase Agreement dated May 6, 2026, and upon completion of the applicable legal, regulatory and other formalities.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	177,873.88 195.45M	0.28% 500.11
ALLSHR	106,712.07 1,040.19M	0.56% 589.19
KSE30	51,887.21 103.81M	0.29% 152.18
KMI30	255,042.46 89.67M	0.46% 1169.47
KMIALLSHR	69,162.85 342.71M	0.85% 584.42
BKTi	48,733.27 19.48M	-0.22% -108.13
OGTi	36,043.06 20.06M	2.70% 947.37

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	68,595.00	71,540.00 67,585.00	-2910.00 -4.07%
BRENT CRUDE	96.30	97.13 95.06	0.48 0.50%
RICHARDS BAY COAL MONTHLY	127.15	0.00 0.00	-1.45 -1.13%
ROTTERDAM COAL MONTHLY	138.00	138.00 137.90	0.60 0.44%
USD RBD PALM OLEIN	1,182.50	1,182.50 1,182.50	0.00 0.00%
CRUDE OIL - WTI	89.07	89.64 87.80	0.33 0.37%
SUGAR #11 WORLD	18.40	18.54 18.16	0.18 0.99%